A new needle-free COVID-19 vaccine has just kicked off trials in the UK, with participants aged between 18 and 50 years of age.
Aiming to protect against future variants of the virus, the vaccine is administered through a jet of air. It was developed by Cambridge University professor Jonathan Heeney and offers an alternative to those afraid of injections.
Heeney said that it is vital to continue producing new generation vaccine candidates which will help us stay safe from the next virus threats.
Called DIOS-CoVax, it varies from other jabs in that the current vaccines use genes taken from the virus spike protein to encode antigens. These cause the immune system to produce antibodies.
The new needle less jab uses predictive methods which mimic the wider family of COVID antigens.
The research facility wherein the trials will be taking place has stated that the new vaccine fights both variants and possible future strains of the virus.
‘This technology could give-wide ranging protection to huge numbers of people worldwide’ the doctor said.
Photo Source: USCF